2-Picolinic Acid

2-Picolinic Acid

SCHEMBL5058098

O=C([O-])c1ccccn1.O=C([O-])c1ccccn1.[Se+2]

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.64
CES1 P23141 1/20 0.64
L3MBTL1 Q9Y468 3/20 0.61
LMNA P02545 3/20 0.61
P4HTM Q9NXG6 2/20 0.61
NAPRT Q6XQN6 1/20 0.61
ALDH1A1 P00352 2/20 0.59
KMT2A Q03164 1/20 0.55
GSK3B P49841 1/20 0.53
KDM4E B2RXH2 4/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MAPT P10636 1/20 0.47
PKM P14618 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Picolinic Acid SCHEMBL11378795 0.98 CES2 (0.67) CES2CES1L3MBTL1LMNAP4HTM
2-Picolinic Acid SCHEMBL6054281 0.95 CES2 (0.64) CES2CES1L3MBTL1LMNAP4HTM
2-Picolinic Acid SCHEMBL15401421 0.95 CES2 (0.64) CES2CES1L3MBTL1LMNAP4HTM
2-Picolinic Acid SCHEMBL1462619 0.95 CES2 (0.64) CES2CES1L3MBTL1LMNAP4HTM
2-Picolinic Acid SCHEMBL2483447 0.95 CES2 (0.64) CES2CES1L3MBTL1LMNAP4HTM
2-Picolinic Acid SCHEMBL524041 0.95 CES2 (0.64) CES2CES1L3MBTL1LMNAP4HTM
2-Picolinic Acid SCHEMBL432467 0.95 CES2 (0.64) CES2CES1L3MBTL1LMNAP4HTM
2-Picolinic Acid SCHEMBL673572 0.95 CES2 (0.64) CES2CES1L3MBTL1LMNAP4HTM
2-Picolinic Acid SCHEMBL5354659 0.95 CES2 (0.64) CES2CES1L3MBTL1LMNAP4HTM
2-Picolinic Acid SCHEMBL15271681 0.95 CES2 (0.64) CES2CES1L3MBTL1LMNAP4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240075043-A1 IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS FOR WEIGHT LOSS Red Mountain Med Spa, LLC (US) 2024-03-07 US claimed
US-20220249505-A1 APPETITE SUPPRESSANT COMPOSITIONS AND METHODS THEREOF RED MOUNTAIN HOLDINGS, LLC (US) 2022-08-11 US claimed
US-20210275536-A1 APPETITE SUPPRESSANT COMPOSITIONS AND METHODS THEREOF RED MOUNTAIN HOLDINGS, LLC (US) 2021-09-09 US claimed
CN-106496924-A A kind of Antibacterial ABS plastic and preparation method thereof 郑州诚合信息技术有限公司 2017-03-15 CN claimed
CN-106496925-A A kind of plastics with antibacterial functions and preparation method thereof 郑州诚合信息技术有限公司 2017-03-15 CN claimed
CN-106333083-A Feed additive for controlling bacterial body-surface ulcer disease of pelteobagrus fulvidraco 广东海因特生物技术集团有限公司 2017-01-18 CN claimed
CN-106170518-A HYDROGEN SULFIDE SCAVENGER 伊诺弗斯公司 2016-11-30 CN claimed
CN-105950009-A Wood wax and preparation method thereof 董学明 2016-09-21 CN claimed
CN-105885691-A High-wear-resistance wood wax oil and preparation method thereof 董学明 2016-08-24 CN claimed
CN-105828783-A Anti-malodor oral care compositions 高露洁-棕榄公司 2016-08-03 CN claimed
CN-101217870-B Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or essential oil components UNIV COLUMBIA 2011-10-12 CN claimed
CN-101163455-B Non-irritating compositions containing zinc salts UNIV COLUMBIA 2011-06-15 CN claimed
CN-101229218-B Vanadium compounds for curing diabetes and preparing method thereof SHENZHEN PUTAILUO BIOLOG TECHNOLOGY CO LTD 2010-12-01 CN claimed
CN-101374526-A Fast acting inhibitors of gastric acid secretion UNIV YALE (US) 2009-02-25 CN claimed
CN-101229218-A Vanadium compounds for curing diabetes and preparing method thereof SHENZHEN PUTAILUO BIOLOG TECHN (CN) 2008-07-30 CN claimed
CN-101163455-A Non-irritating compositions containing zinc salts UNIV COLUMBIA (US) 2008-04-16 CN claimed
US-20070231405-A1 Compositions and Methods Using Same for Treating Neurodegenerative Disorders FUTURE PRODUCTS MANAGEMENT S.A. (VG) 2007-10-04 US claimed
EP-1755625-A1 COMPOSITIONS AND METHODS USING SAME FOR TREATING NEURODEGENERATIVE DISORDERS Future Products Management S.A. (VG) 2007-02-28 EP claimed
WO-2005117924-A1 COMPOSITIONS AND METHODS USING SAME FOR TREATING NEURODEGENERATIVE DISORDERS FUTURE PRODUCTS MANAGEMENT S.A. (VG) 2005-12-15 WO claimed
CN-1080526-A Infect the Therapeutic Method of disease, the anti-corrosion method of cosmetics, antibiotic and antimycotic agent and cosmetics OTSUKA PHARMA CO LTD (JP) 1994-01-12 CN claimed